This site uses cookies to enhance your browsing experience. By continuing navigation, you agree to the use of cookies. For more information about our use of cookies, see our Privacy Policy.

Take Control of Heart Failure

For patients suffering from NYHA Class III heart failure, the Cordella Pulmonary Artery (PA) Sensor and HF System simplifies management at home. It directly connects you with your care team and provides vital heart health insights, including early signs of congestion.

The easy-to-use platform allows you to securely share daily updates on your heart health to inform care decisions, adjust medication between office visits, and actively engage in your care.

What Cordella patients are saying

95%
want to see their health information1
97%
say Cordella is easy to use2
97%
believe PA pressure monitoring and resulting care has a positive health impact1

Clinically Proven to Help You Stay Ahead of HF

Reduction in HF hospitalization rate before and after Cordella use at
12 months

At one year, Cordella enables better HF management and has a proven safety profile with a low complication rate.3

For important risk information, visit www.endotronix.com/risks.

It's easy and simple to use. I feel better knowing my doctor can get information quickly if something changes with my condition.

— Cordella Patient

Easy Setup + Daily Use

Managing your heart failure at home doesn’t have to be complex. Your doctor can track changes in your condition at home and make medication adjustments before an issue occurs.

to submit a daily reading

Learn about the PROACTIVE-HF 2 clinical trial and if you may be a candidate.

LEARN MORE

Your doctor will regularly review your data and determine if medication or other therapy changes may help you.

Download Brochure

English
Download EU Patient Leaflet

Have questions about heart failure?

Learn more

References

  1. Guichard JL. Presented at THT 2023 Boston MA.
  2. Sharif F et al. ESC Heart Fail. 2024Apr; 77(2):7733-7743.
  3. Klein L et al. Seated Pulmonary Artery Pressure Management in Patients with Heart Failure: 12-Month Outcomes in the PROACTIVE-HF Trial. Accepted in JACC-HF.
Important Risk Information